Brain Injury Education and Outpatient Navigation-1stBIEN
Launched by SEATTLE CHILDREN'S HOSPITAL · Feb 18, 2022
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
The 1stBIEN trial is studying a new program designed to help Hispanic families navigate the challenges of recovering from a traumatic brain injury (TBI) in children. This program includes bilingual education sessions and regular video content delivered through mobile phones to help parents understand their child's condition and the rehabilitation process. The goal is to make it easier for families to keep up with follow-up appointments and support their child's recovery after leaving the hospital.
To participate in this trial, children aged 3 to 17 who are Hispanic and have been diagnosed with a mild to severe TBI can enroll, along with their primary caregiver. Participants in the program will receive personalized education and support for three months, while another group will receive standard care. Throughout the study, researchers will track how well families stick to treatment plans, how the child is doing functionally, and the overall well-being of the parents. This trial aims to improve care for Hispanic children with TBIs and could set a standard for supporting families in similar situations.
Gender
ALL
Eligibility criteria
- Children Inclusion criteria:
- • 1. Children 3 to 17 years of age,
- • 2. Hispanic ethnicity
- • 3. Diagnosis of mild, moderate or severe TBI.
- • 4. Hospitalization at one of the 5 academic institutions participating in this trial,
- • 5. Treatment requiring at least one type of rehabilitation therapy as outpatient
- Parent Inclusion Criteria:
- • 1. Hispanic ethnicity
- • 2. Being the primary caregiver for the child (For longitudinal follow-up purposes)
- Exclusion criteria:
- Child:
- • 1. Prior neurological deficits,
- • 2. Acquired brain injuries secondary to other conditions different from trauma.
- • 3. Traumatic brain injuries secondary to abusive trauma.
- Parent:
- • 1. Loss of custody of the child (i.e. abusive head trauma)
- • 2. Inability to be contacted by phone
About Seattle Children's Hospital
Seattle Children's Hospital is a leading pediatric healthcare institution dedicated to advancing the health and well-being of children through innovative clinical research and trials. As a prominent sponsor of clinical studies, the hospital focuses on developing new treatments and therapies that address the unique medical needs of children. With a commitment to excellence, Seattle Children's Hospital collaborates with a network of researchers, healthcare professionals, and academic institutions to ensure rigorous scientific standards and ethical practices in all its clinical investigations. By prioritizing patient safety and scientific integrity, the hospital aims to contribute to the global body of knowledge in pediatric medicine and improve outcomes for children with various health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Salt Lake City, Utah, United States
Seattle, Washington, United States
Dallas, Texas, United States
Portland, Oregon, United States
Salt Lake City, Utah, United States
Seattle, Washington, United States
Colorado Springs, Colorado, United States
Patients applied
Trial Officials
Nathalia Jimenez, MD, MPH
Principal Investigator
Seattle Children's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials